IBX 0.00% 8.5¢ imagion biosystems limited

Ann: First-in-human Study Progress Update, page-16

  1. 47 Posts.
    lightbulb Created with Sketch. 289

    Hello everyone

    IBX has just released an announcement updating the markets on the progress of the MagSense®HER2 breast cancer study.


    Highlights of this announcement include:

    • Interim data supports MagSense® imaging agent is safe and well-tolerated
    • Results make evident that the imaging agent is reaching the patient’s lymph nodes


    CEO Bob Proulxindicates “We are encouraged by these preliminary observations…”


    Read the full announcement here: https://imagionbiosystems.com/news/magsense_her2-breast-cancer-first-in-human-study-progress-update/

    Last edited by ImagionBio: 17/03/22
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.000(0.00%)
Mkt cap ! $2.775M
Open High Low Value Volume
8.4¢ 8.5¢ 8.3¢ $7.711K 91.77K

Buyers (Bids)

No. Vol. Price($)
1 1152 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 1250 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.